Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The PKC targeting protein RACK1 interacts with the Epstein-Barr virus activator protein BZLF1.

Baumann M, Gires O, Kolch W, Mischak H, Zeidler R, Pich D, Hammerschmidt W.

Eur J Biochem. 2000 Jun;267(12):3891-901.

2.

Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation.

Baumann M, Mischak H, Dammeier S, Kolch W, Gires O, Pich D, Zeidler R, Delecluse HJ, Hammerschmidt W.

J Virol. 1998 Oct;72(10):8105-14.

3.

Disruption of Epstein-Barr virus latency in the absence of phosphorylation of ZEBRA by protein kinase C.

El-Guindy AS, Heston L, Endo Y, Cho MS, Miller G.

J Virol. 2002 Nov;76(22):11199-208.

4.

Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.

Gradoville L, Kwa D, El-Guindy A, Miller G.

J Virol. 2002 Jun;76(11):5612-26.

6.

The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.

Hergenhahn M, Soto U, Weninger A, Polack A, Hsu CH, Cheng AL, Rösl F.

Mol Carcinog. 2002 Mar;33(3):137-45.

PMID:
11870879
7.

Epstein-Barr virus BZLF1 transactivator is a negative regulator of Jun.

Sato H, Takeshita H, Furukawa M, Seiki M.

J Virol. 1992 Aug;66(8):4732-6.

8.

Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.

Zhang Q, Hong Y, Dorsky D, Holley-Guthrie E, Zalani S, Elshiekh NA, Kiehl A, Le T, Kenney S.

J Virol. 1996 Aug;70(8):5131-42.

10.
11.
12.

Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.

Daibata M, Speck SH, Mulder C, Sairenji T.

Virology. 1994 Feb;198(2):446-54.

PMID:
8291228
13.

The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.

Robinson AR, Kwek SS, Kenney SC.

PLoS Pathog. 2012 Feb;8(2):e1002516. doi: 10.1371/journal.ppat.1002516. Epub 2012 Feb 9.

14.

Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.

Kraus RJ, Mirocha SJ, Stephany HM, Puchalski JR, Mertz JE.

J Virol. 2001 Jan;75(2):867-77.

15.

Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early protein.

Nakayama S, Murata T, Murayama K, Yasui Y, Sato Y, Kudoh A, Iwahori S, Isomura H, Kanda T, Tsurumi T.

J Biol Chem. 2009 Aug 7;284(32):21557-68. doi: 10.1074/jbc.M109.015685. Epub 2009 Jun 2.

16.
18.

Phosphorylation of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA.

Daibata M, Humphreys RE, Sairenji T.

Virology. 1992 Jun;188(2):916-20.

PMID:
1316687
19.

Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1.

Schepers A, Pich D, Hammerschmidt W.

Virology. 1996 Jun 15;220(2):367-76.

20.

Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-beta through cooperativity of Smads and c-Jun/c-Fos proteins.

Liang CL, Chen JL, Hsu YP, Ou JT, Chang YS.

J Biol Chem. 2002 Jun 28;277(26):23345-57. Epub 2002 Apr 23.

Supplemental Content

Support Center